NCT04165317 2026-01-22
CREST
Pfizer
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT05037279 2025-02-20
EVER
Verity Pharmaceuticals Inc.
Phase 3 Recruiting
NCT02792192 2021-10-28
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants
Hoffmann-La Roche
Phase 1/2 Terminated
NCT00694915 2021-08-17
STCC
Cadila Pharnmaceuticals
Phase 2 Completed
NCT02010203 2020-02-17
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT
Heat Biologics
Phase 1/2 Terminated
NCT01284205 2014-08-29
First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC
Bioniche Life Sciences Inc.
Phase 3 Withdrawn